Adalimumab-Aacf
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Analysis of Suffix Use for Biosimilar Product Identification in Postmarketing Adverse Event Reporting.
Journal: Clinical pharmacology and therapeutics
Published: April 14, 2026
Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with rheumatoid arthritis: a 12-month observational study.
Journal: Advances in rheumatology (London, England)
Published: March 07, 2025
Comparing adalimumab biosimilars in the clinical practice of psoriatic patients.
Journal: Italian journal of dermatology and venereology
Published: February 03, 2025
Evaluation of Methods Employed in Establishing Preclinical Similarity of Adalimumab Biosimilars.
Journal: Advances in pharmacological and pharmaceutical sciences
Published: December 09, 2024
Navigating adalimumab biosimilars: an expert opinion.
Journal: Journal of comparative effectiveness research
Published: October 19, 2023
Effectiveness and safety of adalimumab biosimilar in patients with inflammatory bowel disease.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: October 11, 2023
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience.
Journal: The Journal of dermatological treatment
Published: June 05, 2023
Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers.
Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers.
Journal: International journal of pharmaceutics: X
Published: May 14, 2023
Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia.
Journal: Expert opinion on biological therapy
Published: April 18, 2023
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis.
Journal: Expert opinion on biological therapy
Published: April 25, 2022
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis.
Journal: Dermatology and therapy
Published: February 28, 2022
Expanded Table: Some biologic drugs and JAK inhibitors for rheumatoid arthritis.
Journal: The Medical letter on drugs and therapeutics
Published: January 27, 2022
Last Updated: 09/26/2026